Green technology transfer of new drug candidates based on hydroxyazole structure in advanced preclinical phase for the treatment of Acute Myeloid Leukaemia (AML) and Covid 19(2025 Jun 26).
Green technology transfer of new drug candidates based on hydroxyazole structure in advanced preclinical phase for the treatment of Acute Myeloid Leukaemia (AML) and Covid 19
MANNELLA, IOLE
2025-06-26
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PhD Thesis IOLE MANNELLA.pdf
Accesso aperto
Descrizione: Tesi
Dimensione
5.97 MB
Formato
Adobe PDF
|
5.97 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
